733237447	733237447	CD	B-NP	O
|	|	NN	I-NP	O
ARBUH	ARBUH	NN	I-NP	O
|	|	NN	I-NP	O
72237178	72237178	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7356143	7356143	CD	B-NP	O
|	|	CC	I-NP	O
9/23/2005	9/23/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
FEMORAL	FEMORAL	NNP	I-NP	I-protein
FRACTURE	FRACTURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/23/2005	9/23/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/18/2005	10/18/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DEGASPARRE	DEGASPARRE	NN	B-NP	O
,	,	,	O	O
ABE	ABE	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
CARE	CARE	NN	I-NP	O
PHYSICIAN	PHYSICIAN	NN	I-NP	O
:	:	:	O	O
Sid	Sid	NNP	B-NP	O
Bresler	Bresler	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Phone	Phone	NNP	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
-LRB-	-LRB-	SYM	B-ADJP	O
436	436	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
-271	-271	CD	I-NP	O
-8119	-8119	CD	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
FOR	FOR	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Left	Leave	VBN	B-NP	O
femur	femur	NN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

PROBLEMS	PROBLEMS	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
femur	femur	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Delirium	Delirium	NN	B-NP	O
on	on	IN	B-PP	O
baseline	baseline	NN	B-NP	O
dementia	dementia	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hyponatremia	Hyponatremia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
incisional	incisional	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76-year-old	76-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
past	past	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
osteopetrosis	osteopetrosis	NN	B-NP	O
,	,	,	O	O
persistent	persistent	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
dementia	dementia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
transfer	transfer	NN	I-NP	O
from	from	IN	B-PP	O
DCMC	DCMC	NN	B-NP	B-cell_type
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Bona	Bona	NNP	I-NP	O
Pase	Pase	NNP	I-NP	O
Ro	Ro	NNP	I-NP	O
Health	Health	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nondisplaced	nondisplaced	JJ	I-NP	O
hairline	hairline	NN	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
neck	neck	NN	I-NP	O
noted	note	VBN	B-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
sudden	sudden	JJ	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
describes	describe	VBZ	B-VP	O
her	her	PRP	B-NP	B-protein
developing	develop	VBG	B-VP	I-protein
leg	leg	NN	B-NP	I-protein
pain	pain	NN	I-NP	I-protein
when	when	WRB	B-ADVP	O
weightbearing	weightbeare	VBG	B-VP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
car	car	NN	B-NP	B-protein
in	in	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
recent	recent	JJ	I-NP	O
fall	fall	NN	I-NP	O
and	and	CC	I-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

Transfer	Transfer	NN	B-NP	O
paper	paper	NN	I-NP	O
from	from	IN	B-PP	O
SH	SH	NN	B-NP	O
suggest	suggest	VBP	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
fallen	fall	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
states	state	NNS	I-NP	O
,	,	,	O	O
Ms.	Ms.	NNP	B-NP	O
Maisey	Maisey	NNP	I-NP	O
can	can	MD	B-VP	O
walk	walk	VB	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
,	,	,	O	O
uses	use	VBZ	B-VP	O
bathroom	bathroom	NN	B-NP	O
herself	herself	PRP	B-NP	O
,	,	,	O	O
feed	feed	VB	B-VP	O
herself	herself	PRP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
handle	handle	VB	B-VP	O
petty	petty	JJ	B-NP	O
cash	cash	NN	I-NP	O
and	and	CC	O	O
recognizes	recognize	VBZ	B-VP	O
family	family	NN	B-NP	O
members	member	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
needs	need	VBZ	B-VP	O
assistance	assistance	NN	B-NP	O
with	with	IN	B-PP	O
bathing	bathing	NN	B-NP	O
and	and	CC	I-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
actual	actual	JJ	I-NP	O
daily	daily	JJ	I-NP	O
living	living	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
confused	confuse	VBN	I-VP	O
since	since	IN	B-PP	O
early	early	RB	B-ADVP	O
after	after	IN	B-SBAR	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
MMHC	MMHC	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Debem	Debem	NNP	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
suffered	suffer	VBN	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
difficulties	difficulty	NNS	B-NP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
recalls	recall	VBZ	B-VP	O
for	for	IN	B-PP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
did	do	VBD	B-VP	O
send	send	VB	I-VP	O
copies	copy	NNS	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
vicinity	vicinity	NN	I-NP	O
inspect	inspect	NN	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
2005	2005	CD	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
and	and	CC	I-NP	O
echocardiography	echocardiography	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Orthopedic	Orthopedic	NNP	I-NP	O
Service	Service	NNP	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
hip	hip	NN	B-NP	O
replacement	replacement	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
osteopetrosis	osteopetrosis	NN	B-NP	O
,	,	,	O	O
dementia	dementia	NN	B-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
TKR	TKR	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
laminectomy	laminectomy	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cholecystectomy	cholecystectomy	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
brother	brother	NN	B-NP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
husband	husband	NN	B-NP	O
Macall	Macall	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
-LRB-	-LRB-	SYM	B-ADJP	O
337	337	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
-736	-736	CD	I-NP	O
-0287	-0287	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Unavailable	Unavailable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
obtain	obtain	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
confusion	confusion	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICINES	MEDICINES	NNS	B-NP	O
ON	ON	NN	I-NP	O
TRANSFER	TRANSFER	NN	I-NP	O
:	:	:	O	O
Zocor	Zocor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Remeron	Remeron	NNP	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg/4	mg/4	NN	I-NP	O
mg	mg	NN	I-NP	O
alternating	alternate	VBG	B-VP	O
q.o.d.	q.o.d.	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mcg/0	mcg/0	CD	I-NP	O
.25	.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
alternating	alternate	VBG	B-VP	O
q.o.d.	q.o.d.	NN	B-NP	O
,	,	,	O	O
Cymbalta	Cymbalta	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	NNP	B-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Risperdal	Risperdal	JJ	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
propranolol	propranolol	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
96.9	96.9	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
94	94	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
142/68	142/68	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
somnolent	somnolent	JJ	B-ADJP	O
,	,	,	O	O
arousable	arousable	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
confused	confuse	VBD	B-VP	O
but	but	CC	O	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Normocephalic	Normocephalic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
atraumatic	atraumatic	JJ	I-ADJP	O
.	.	.	O	O

Anicteric	Anicteric	JJ	B-NP	O
sclerae	sclerae	NNS	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
round	round	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
moist	moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
with	with	IN	B-PP	O
full	full	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
had	have	VBD	B-VP	O
faint	faint	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
right	right	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
irregularly	irregularly	RB	B-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
.	.	.	O	O

JVD	JVD	NN	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	O	O
mildly	mildly	RB	B-VP	O
distended	distend	VBN	I-VP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

DP	DP	NN	B-NP	O
were	be	VBD	B-VP	O
palpable	palpable	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
to	to	TO	B-PP	O
self	self	PRP	B-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
somnolent	somnolent	JJ	B-NP	O
,	,	,	I-NP	O
follow	follow	JJ	I-NP	O
command	command	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
TESTS	TESTS	NNS	I-NP	O
AND	AND	CC	I-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
TSH	TSH	NN	B-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
head	head	NN	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
old	old	JJ	I-NP	O
small	small	JJ	I-NP	O
left	left	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
frontal	frontal	JJ	I-NP	O
contusion	contusion	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
pelvis	pelvis	NN	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
hairline	hairline	NN	I-NP	O
left	leave	VBD	B-VP	O
femur	femur	NN	B-NP	O
fracture	fracture	NN	I-NP	O
plus	plus	CC	O	O
osteopetrosis	osteopetrosis	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
but	but	CC	O	O
otherwise	otherwise	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
taken	take	VBN	B-VP	O
on	on	RP	B-PRT	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

Stool	Stool	NNP	B-NP	O
Clostridium	Clostridium	NNP	I-NP	O
difficile	difficile	NN	I-NP	O
,	,	,	O	O
toxin	toxin	NN	B-NP	O
assay	assay	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
taken	take	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
February	February	NNP	I-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
following	follow	VBG	B-PP	O
surgery	surgery	NN	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
right	right	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
somewhat	somewhat	RB	B-VP	O
improved	improve	VBN	I-VP	O
over	over	IN	B-PP	O
prior	prior	JJ	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Leslie	Leslie	NNP	I-NP	O
did	do	VBD	B-VP	O
a	a	DT	B-NP	O
Girdlestone	Girdlestone	NNP	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Hepp	Hepp	NNP	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
hemiarthroplasty	hemiarthroplasty	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
dictated	dictated	JJ	I-NP	O
operative	operative	JJ	I-NP	O
notes	note	NNS	I-NP	O
for	for	IN	B-PP	O
details	detail	NNS	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76-year-old	76-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
dementia	dementia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
for	for	IN	B-PP	O
orthopedic	orthopedic	JJ	B-NP	O
surgical	surgical	JJ	I-NP	O
correction	correction	NN	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
surgery	surgery	NN	I-NP	O
but	but	CC	B-PP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
delirium	delirium	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
new	new	JJ	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Ortho	Ortho	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
femur	femur	NN	I-NP	O
hairline	hairline	NN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Girdlestone	Girdlestone	NN	I-NP	O
procedure	procedure	NN	I-NP	O
performed	perform	VBN	B-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
hemiarthroplasty	hemiarthroplasty	NN	I-NP	O
performed	perform	VBN	B-VP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
postoperatively	postoperatively	RB	B-ADVP	O
with	with	IN	B-PP	O
cefazolin	cefazolin	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discharged	discharge	VBN	I-VP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
incisional	incisional	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
abscess	abscess	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
preop	preop	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
determined	determine	VBN	I-NP	O
intermediate	intermediate	JJ	I-NP	O
risk	risk	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mildly	mildly	RB	B-ADJP	O
hypertensive	hypertensive	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rates	rate	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
140s	140	NNS	I-NP	B-DNA
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
and	and	CC	O	O
p.o.	p.o.	FW	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
digoxin	digoxin	NN	B-NP	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
IV	IV	CD	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
loaded	load	VBN	B-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
undergoing	undergo	VBG	I-VP	O
a	a	DT	B-NP	O
p.o.	p.o.	NN	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

To	To	TO	B-PP	O
date	date	NN	B-NP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
current	current	JJ	B-NP	O
loading	loading	NN	I-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
seven	seven	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	RB	B-ADVP	O
indefinitely	indefinitely	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
weight	weight	NN	B-NP	O
controlled	control	VBN	B-VP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rates	rate	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	NN	I-NP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
getting	get	VBG	I-VP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
300	300	CD	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
dementia	dementia	NN	I-NP	O
and	and	CC	O	O
per	per	IN	B-PP	O
husband	husband	NN	B-NP	O
was	be	VBD	B-VP	O
developing	develop	VBG	I-VP	O
delirium	delirium	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
to	to	TO	B-PP	O
Bingvent	Bingvent	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

Differential	Differential	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
delirium	delirium	NN	I-NP	O
infection	infection	NN	I-NP	O
versus	versus	IN	B-PP	O
medications	medication	NNS	B-NP	O
versus	versus	IN	B-PP	O
electrolytes	electrolyte	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
stress	stress	NN	B-NP	O
of	of	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
initially	initially	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Cymbalta	Cymbalta	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
hyponatremia	hyponatremia	NN	B-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
slowly	slowly	RB	I-VP	O
improved	improve	VBN	I-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
new	new	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	RB	B-ADVP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
report	report	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
UTI	UTI	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
postop	postop	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
of	of	IN	B-PP	O
cefazolin	cefazolin	NN	B-NP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
September	September	NNP	I-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
to	to	TO	B-PP	O
23	23	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
stool	stool	NN	B-NP	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
has	have	VBZ	B-VP	O
subsequently	subsequently	RB	I-VP	O
come	come	VBN	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
17	17	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Keflex	Keflex	NNP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
incisional	incisional	JJ	I-NP	O
site	site	NN	I-NP	O
mild	mild	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
staples	staple	NNS	I-NP	O
were	be	VBD	B-VP	O
out	out	RB	B-ADVP	O
after	after	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
nonbloody	nonbloody	JJ	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

C.	C.	FW	B-NP	O
difficile	difficile	JJ	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
come	come	VBN	I-VP	O
back	back	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
prophylactic	prophylactic	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
postop	postop	NN	I-NP	O
but	but	CC	O	O
never	never	RB	B-ADVP	O
was	be	VBD	B-VP	O
compromised	compromise	VBN	I-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
oxygenation	oxygenation	NN	B-NP	O
or	or	CC	I-NP	O
ventilation	ventilation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
making	make	VBG	I-VP	O
modest	modest	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
self	self	PRP	B-NP	O
diuresing	diurese	VBG	B-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
140	140	CD	B-NP	O
which	which	WDT	B-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
gradually	gradually	RB	I-VP	O
dropped	drop	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
nadir	nadir	NN	I-NP	O
of	of	IN	B-PP	O
119	119	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
November	November	NNP	I-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
med	med	JJ	I-NP	O
changes	change	NNS	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
SSRI	SSRI	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
free-water	free-water	JJ	B-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	O
lytes	lyte	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
lytes	lyte	NNS	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
picture	picture	NN	B-NP	O
of	of	IN	B-PP	O
SIADH	SIADH	NN	B-NP	B-protein
,	,	,	O	O
so	so	RB	O	O
free-water	free-water	JJ	B-NP	O
restriction	restriction	NN	I-NP	O
has	have	VBZ	B-VP	O
worked	work	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
is	be	VBZ	B-VP	O
131	131	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
free-water	free-water	JJ	B-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	O	O
recheck	recheck	VB	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
fat	fat	NN	I-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
sugars	sugar	NNS	I-NP	O
are	be	VBP	B-VP	O
moderately	moderately	RB	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
coverage	coverage	NN	B-NP	O
on	on	IN	B-PP	O
top	top	NN	B-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
was	be	VBD	B-VP	O
euthyroid	euthyroid	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limit	limit	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
Synthroid	Synthroid	JJ	I-NP	O
continued	continue	VBN	B-VP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
indefinitely	indefinitely	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NNP	B-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
prophylactic	prophylactic	JJ	I-NP	O
dose	dose	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
following	follow	VBG	B-PP	O
surgery	surgery	NN	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
and	and	CC	O	O
up	up	RB	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
2.0	2.0	CD	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
fell	fall	VBN	I-VP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
transfused	transfuse	VBN	I-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
then	then	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
appropriately	appropriately	RB	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	B-protein
was	be	VBD	B-VP	I-protein
39.0	39.0	CD	B-NP	I-protein
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
Given	Give	VBN	B-VP	O
her	her	PRP$	B-NP	O
high	high	JJ	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
DVTs	DVT	NNS	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
prophylactic	prophylactic	JJ	B-ADJP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
while	while	IN	B-SBAR	O
waiting	wait	VBG	B-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
to	to	TO	B-VP	O
become	become	VB	I-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
given	give	VBN	B-VP	O
pneumo	pneumo	NN	B-NP	O
boots	boot	NNS	I-NP	O
and	and	CC	O	O
TED	TED	VBN	B-NP	O
stocking	stocking	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Nexium	Nexium	NNP	B-NP	O
for	for	IN	B-PP	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
consultants	consultant	NNS	I-NP	O
were	be	VBD	B-VP	O
called	call	VBN	I-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
service	service	NN	I-NP	O
initial	initial	JJ	B-ADJP	O
have	have	VBP	B-VP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
contact	contact	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Scott	Scott	NNP	I-NP	O
E	E	NNP	I-NP	O
Kercy	Kercy	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
T	T	NN	I-NP	O
max	max	NN	I-NP	O
of	of	IN	B-PP	O
97.9	97.9	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
between	between	IN	B-PP	O
49	49	CD	B-NP	O
and	and	CC	I-NP	O
64	64	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
between	between	IN	B-PP	O
98	98	CD	B-NP	O
and	and	CC	I-NP	O
120/44	120/44	CD	I-NP	O
to	to	TO	I-NP	O
60	60	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
breathing	breathing	JJ	B-NP	O
18	18	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
and	and	CC	O	O
satting	satte	VBG	B-VP	O
between	between	IN	B-PP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Fasting	Fast	VBG	B-NP	O
sugars	sugar	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x2	x2	NN	B-NP	O
to	to	TO	B-PP	O
place	place	NN	B-NP	O
and	and	CC	O	O
person	person	NN	B-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
alert	alert	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
situation	situation	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
anicteric	anicteric	JJ	B-NP	O
sclerae	sclerae	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
slightly	slightly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
or	or	CC	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
irregularly	irregularly	RB	B-NP	O
irregular	irregular	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
obese	obese	JJ	I-ADJP	O
with	with	IN	B-PP	O
mildly	mildly	RB	B-NP	O
distended	distend	VBN	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
left	leave	VBN	I-VP	O
hip	hip	NN	B-NP	O
incision	incision	NN	I-NP	O
with	with	IN	B-PP	O
staples	staple	NNS	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
dehiscence	dehiscence	NN	B-NP	O
but	but	CC	O	O
a	a	DT	B-NP	O
5	5	CD	I-NP	O
cm	cm	NN	I-NP	O
round	round	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	B-protein
exam	exam	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICINES	MEDICINES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
headache	headache	NN	I-NP	O
,	,	,	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
exceed	exceed	VB	I-VP	O
4	4	CD	B-NP	O
g	g	NN	I-NP	O
in	in	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
x7	x7	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
indefinitely	indefinitely	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.r.	p.r.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	B-protein
carbonate	carbonate	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Ferrous	Ferrous	JJ	B-NP	B-protein
sulfate	sulfate	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Folate	Folate	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
12	12	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
give	give	NN	I-NP	O
0	0	CD	B-NP	O
,	,	,	O	O
125	125	CD	B-NP	O
to	to	TO	I-NP	O
150	150	CD	I-NP	O
give	give	NN	I-NP	O
2	2	CD	B-NP	O
,	,	,	O	O
151	151	CD	B-NP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
,	,	,	O	O
201	201	CD	B-NP	O
to	to	TO	I-NP	O
250	250	CD	I-NP	O
give	give	NN	I-NP	O
4	4	CD	B-NP	O
,	,	,	O	O
251	251	CD	B-NP	O
to	to	TO	I-NP	O
300	300	CD	I-NP	O
give	give	NN	I-NP	O
6	6	CD	B-NP	O
,	,	,	I-NP	O
301	301	CD	I-NP	O
to	to	TO	I-NP	O
350	350	CD	I-NP	O
give	give	NN	I-NP	O
8	8	CD	B-NP	O
,	,	,	I-NP	O
351	351	CD	I-NP	O
to	to	TO	I-NP	O
400	400	CD	I-NP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Milk	Milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

M.V.I.	M.V.I.	LS	B-LST	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Metamucil	Metamucil	NNP	B-NP	O
sugarfree	sugarfree	VBP	B-VP	O
one	one	CD	B-NP	O
packet	packet	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Sarna	Sarna	NNP	B-NP	O
topical	topical	JJ	I-NP	O
q.d.	q.d.	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Fleet	Fleet	NNP	B-NP	O
Enema	Enema	NNP	I-NP	O
one	one	CD	I-NP	O
bottle	bottle	NN	I-NP	O
p.r.	p.r.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Keflex	Keflex	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
x7	x7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
55	55	CD	B-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Risperdal	Risperdal	JJ	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Remeron	Remeron	NNP	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Miconazole	Miconazole	NN	B-NP	O
powder	powder	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
22	22	CD	I-NP	O
.	.	.	O	O

Cholecalciferol	Cholecalciferol	NN	B-NP	B-protein
400	400	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	NN	B-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Rehabilitation	Rehabilitation	NN	I-NP	O
Facility	Facility	NN	I-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

PHYSICIAN	PHYSICIAN	NN	B-NP	O
PLANS	PLANS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Ortho	Ortho	NNP	B-NP	O
,	,	,	O	O
discontinued	discontinue	VBD	B-VP	O
staples	staple	NNS	B-NP	O
on	on	IN	B-PP	O
postop	postop	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
14	14	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
followup	followup	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gantner	Gantner	NNP	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
x-rays	x-ray	NNS	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Parris	Parris	NNP	I-NP	O
himself	himself	PRP	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
Phone	Phone	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
-LRB-	-LRB-	SYM	B-ADJP	O
215	215	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
-306	-306	CD	I-NP	O
-1024	-1024	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

A.	A.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
.	.	.	O	O

Make	Make	NN	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
and	and	CC	I-NP	O
Toprol	Toprol	NN	I-NP	O
holding	holding	NN	I-NP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

C	C	NN	B-NP	O
:	:	:	O	O
Rhythm	Rhythm	NN	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
400	400	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
starting	start	VBG	B-VP	O
at	at	IN	B-PP	O
5th	5th	JJ	B-ADJP	O
and	and	CC	O	O
then	then	RB	O	O
afterwards	afterwards	RB	B-NP	O
400	400	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
indefinitely	indefinitely	RB	B-ADVP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
Toprol-XL	Toprol-XL	NNP	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
and	and	CC	O	O
consider	consider	VB	B-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
Toprol	Toprol	NN	B-NP	O
for	for	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
for	for	IN	B-PP	O
assessment	assessment	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	O
goal	goal	NN	I-NP	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
P.O.	P.O.	NNP	B-NP	O
Keflex	Keflex	NNP	I-NP	O
until	until	IN	B-PP	O
staples	staple	NNS	B-NP	O
out	out	IN	B-ADVP	O
in	in	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
follow	follow	NN	I-NP	O
for	for	IN	B-PP	O
assessment	assessment	NN	B-NP	O
in	in	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
Free-water	Free-water	JJ	B-NP	O
restriction	restriction	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
followup	followup	NN	B-NP	O
sodium	sodium	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
if	if	IN	B-SBAR	O
sodium	sodium	NN	B-NP	O
scaled	scale	VBD	B-VP	O
to	to	TO	B-PP	O
135	135	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
can	can	MD	B-VP	O
have	have	VB	I-VP	O
regular	regular	JJ	B-NP	O
ADA	ADA	NN	I-NP	O
2000	2000	CD	I-NP	O
per	per	IN	B-PP	O
calorie	calorie	NN	B-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
salt	salt	NN	I-NP	O
added	add	VBD	B-VP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NNP	B-NP	O
:	:	:	O	O
Continue	Continue	JJ	B-NP	O
NPH	NPH	NN	I-NP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
coverage	coverage	NN	B-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
Synthroid	Synthroid	NNP	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
current	current	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
pneumatic	pneumatic	JJ	B-NP	O
boots	boot	NNS	I-NP	O
for	for	IN	B-PP	O
TEDs	TED	NNS	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
given	give	VBN	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
following	follow	VBG	B-PP	O
an	an	DT	B-NP	O
orthopedic	orthopedic	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-0898894	6-0898894	CD	B-NP	O
SSSten	SSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BURKHAMMER	BURKHAMMER	NNP	B-NP	O
,	,	,	O	O
ROY	ROY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CALLOW	CALLOW	NNP	B-NP	O
,	,	,	O	O
BLAINE	BLAINE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3984866	3984866	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/23/05	9/23/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/23/05	9/23/05	CD	B-NP	O

